Kirk Davis - Aug 12, 2024 Form 4 Insider Report for HARTE HANKS INC (HHS)

Role
Chief Executive Officer
Signature
/s/ Robert Wyman, Attorney-in-fact for Kirk Davis
Stock symbol
HHS
Transactions as of
Aug 12, 2024
Transactions value $
$49,999
Form type
4
Date filed
8/12/2024, 02:32 PM
Previous filing
May 13, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HHS Common Stock Purchase $49.6K +7.08K +31.71% $7.00 29.4K Aug 12, 2024 Direct F1
transaction HHS Common Stock Purchase $425 +61 +0.21% $6.96 29.5K Aug 12, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding HHS Option to buy Common Shares 240K Aug 12, 2024 Common Stock 240K $5.59 NQ stock options granted and held by Harte Hanks, Inc. until exercised. F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Participant purchased common shares.
F2 NQ stock options granted on August 14, 2023 under the Harte Hanks, Inc. 2023 Inducement Equity Incentive Plan. The options vest and become exercisable as to 1/3rd of the underlying shares on each of the first three anniversaries of June 19, 2023.